REVIEW PAPER
Progress in the treatment for osteoarthritis of the spine
More details
Hide details
Submission date: 2013-06-19
Acceptance date: 2013-11-18
Online publication date: 2013-12-24
Publication date: 2013-12-20
Reumatologia 2013;51(6):429-436
KEYWORDS
TOPICS
ABSTRACT
Degenerative disease of the spine is characterized by progressive lesion of intervertebral discs and cartilage of the zygapophyseal joint. This exposes joint capsules and ligaments to microtraumatization. Healing starts with local inflammation, then it follows with corrective hypertrophy of the osseous tissue. The degenerative process can lead to a loss of stability of the spine, herniation of discs, or spinal stenosis with or without any neurological symptomatology. Then, apart from nociceptor arthralgia, radicular pain, neuropathic pain or neurogenic claudication may occur. Neurological complications, such as muscle weakness, sensory and sphincter disorders, alongside long-lasting pain, form the clinical picture of the disease. This paper discusses the progress in the treatment of pain, taking into consideration the psycho-social conditions of patients and the progress in surgical treatment of complications of degenerative spine disease. Because the degenerative spine disease itself is not curable, changing it into an asymptomatic form would be a success.
REFERENCES (44)
1.
Bibby SR, Yu J, Urban JP. The Physiology of Intervertebral Disc Degeneration. In: Degenerative Disc Disease, Ginzburg R, Szpalski M, Andersson G (eds.). Lippincott Williams & Wilkins, Philadelphia 2004; 23-34.
2.
Butler D, Trafimow JH, Andersson GB, et al. Discs degenerate before facets. Spine (Phila Pa 1976) 1990; 15: 111-113.
3.
Styczyński T. Objaw „zwiększonej powierzchni podparcia kręgów” u chorych na przepuklinę krążka międzykręgowego. Pol Przegl Rad 1984; 48: 71-73.
4.
Boos N, Semmer N, Elfering A, et al. Natural history of individuals with asymptomatic disc abnormalities in magnetic resonance imaging: predictors of low back pain-related medical consultation and work incapacity. Spine (Phila Pa 1976) 2000; 25: 1484-1492.
5.
Jarvik JJ, Hollingworth W, Heagerty P, et al. The Longitudinal Assessment of Imaging and Disability of the Back (LAIDBack) Study: baseline data. Spine (Phila Pa 1976) 2001; 26: 1158-1166.
6.
Powell MC, Wilson M, Szypryt P, et al. Prevalence of lumbar disc degeneration observed by magnetic resonance in symptomless women. Lancet 1986; 2: 1366-1367. .
7.
Weishaupt D, Zanetti M, Hodler J, Boos N. MR imaging of the lumbar spine: prevalence of intervertebral disk extrusion and sequestration, nerve root compression, end plate abnormalities, and osteoarthritis of the facet joints in asymptomatic volunteers. Radiology 1998; 209: 661-666.
8.
Osterman K, Schlenzka D, Poussa M, et al. Isthmic spondylolisthesis in symptomatic and asymptomatic subjects, epidemiology, and natural history with special reference to disk abnormality and mode of treatment. Clin Orthop 1993; 297: 65-70.
9.
Carragee EJ, Paragioudakis SJ, Khurana S. 2000 Volvo Award winner in clinical studies: Lumbar high-intensity zone and discography in subjects without low back problems. Spine (Phila Pa 1976) 2000; 25: 2987-2992.
10.
Jensen MC, Brant-Zawadzki MN, Obuchowski N, et al. Magnetic resonance imaging of the lumbar spine in people without back pain. N Engl J Med 1994; 331: 69-73.
11.
Boden SD, McCowin PR, Davis DO, et al. Abnormal magnetic-resonance scans of the cervical spine in asymptomatic subjects. A prospective investigation. J Bone Joint Surg Am 1990; 72: 403-408.
12.
White A, Panjabi M. Clinical Biomechanics of the Spine. Lippincott Williams & Wilkins, Baltimore 1990.
13.
Chou R, Qaseem A, Snow V, et al.; Clinical Efficacy Assessment Subcommittee of the American College of Physicians; American College of Physicians; American Pain Society Low Back Pain Guidelines Panel. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 2007; 147: 478-491. .
14.
Olmarker K, Blomquist J, Strömberg J, et al. Inflammatogenic properties of nucleus pulposus. Spine (Phila Pa 1976) 1995; 20: 665-669.
15.
Goupille P, Mulleman D, Vacat JP. Radiculopathy associated with disc herniation. Ann Rheum Dis 2006; 65: 141-143.
16.
Goupille P, Jayson MI, Valat JP, Freemont AJ. The role of inflammation in disk herniation-associated radiculopathy. Semin Arthritis Rheum 1998; 28: 60-71.
17.
World Health Organization: Cancer pain relief and palliative care. Word Health Organization, Geneva 1990. .
18.
Dolan AL, Ryan PJ, Arden NK, et al. The value of SPECT scans in identifying back pain likely to benefit from facet joint injection. Br J Rheumatol 1996; 35: 1269-1273.
19.
Kaplan M, Dreyfuss P, Halbrook B, Bogduk N. The ability of lumbar medial branch blocks to anesthetize the zygapophysial joint. A physiologic challenge. Spine (Phila Pa 1976) 1998; 23: 1847-1852.
20.
Dreyfuss P, Halbrook B, Pauza K, et al. Efficacy and validity of radiofrequency neurotomy for chronic lumbar zygapophysial joint pain. Spine (Phila Pa 1976) 2000; 25: 1270-1277.
21.
Styczyński T. Zmiany zwyrodnieniowe kręgosłupa a leczenie i problem społeczny. Post N Med 2010; 23: 474-482.
22.
Gasik R, Styczyński T. Charakterystyka kliniczna chorych z bólem neuropatycznym w przebiegu przepuklin lędźwiowych krążków międzykręgowych. Reumatologia 2001; 39: 361-364. .
23.
Dworkin RH, O'Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 2010; 85 (suppl): 3-14.
24.
Finnerup NB, Sindrup SH, Jansen TS. The evidence for pharmacological treatment of neuropathic pain. Pain 2010; 150: 573-581.
25.
Attal N, Cruccu G, Baron R, et al.; European Federation of Neurological Societies. EFNS guidelines on pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neur 2010; 17: 1113-1123.
26.
Manaka M, Komagata M, Endo K, Imakiire A. Assessment of lumbar spinal canal stenosis by magnetic resonance phlebography. J Orthop Sci 2003; 8: 1-5.
27.
Amundsen T, Weber H, Nordal HJ, et al. Lumbar spinal stenosis. Conservative or surgical management? A prospective 10-year study. Spine (Phila Pa 1976) 2000; 25: 1424-1435.
28.
Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med 2003; 163: 2433-2445.
29.
Matejuk-Mazurek I, Mierzejewski P. Ból i depresja. Na czym polega efekt przeciwbólowy wenlafaksyny? Opis przypadków. Neuropsychiatr Przegl Klin 2012; 4: 174-177.
30.
Linton SJ. A review of psychological risk factors in back and neck pain. Spine (Phila Pa 1976) 2000; 25: 1148-1156.
31.
Koes BW, van Tulder MW, Ostelo R, et al. Clinical guidelines for the management of low back pain in primary care. Spine (Phila Pa 1976) 2001; 26: 1504-1514.
32.
Burton AK, Waddell G, Tillotson KM, Summerton N. Information and advice to patients with back pain can have a positive effect. A randomized controlled trial of a novel educational booklet in primary care. Spine (Phila Pa 1976) 1994; 24: 2484-2491.
33.
Hilfiker R, Bachmann LM, Heitz CA, et al. Value of predictive instruments to determine persisting restriction of function in patients with subacute non-specific low back pain. Systematic review. Eur Spine J 2007; 16: 1755-1775.
34.
Hoogendoorn WE, van Poppel MN, Bongers PM, et al. Systematic review of psychosocial factors at work and private life as risk factors for back pain. Spine (Phila Pa 1976) 2000; 25: 2114-2125.
35.
Kendall N, Linton S, Main C. Guide to assessing psychosocial yellow flags In acute low back pain: risk factors for long- term disability and work loss. Accident Rehabilitation & Compensation Insurance Corporation of New Zealand and the National Health Committee, Wellington 1997.
36.
Kovacs FM, Abraira V, Zamora J, et al. The transition from acute to subacute and chronic low back pain: a study based on determinants of quality of life and prediction of chronic disability. Spine (Phila Pa 1976) 2005; 30: 1786-1792.
37.
Leboeuf-Yde C. Body weight and low back pain. A systematic literature review of 56 journal articles reporting on 65 epidemiologic studies. Spine (Phila Pa 1976) 2000; 25: 226-237.
38.
Atlas SJ, Cardin RA. Evaluation and treatment of low back pain: an evidence-based approach to clinical care. Muscle Nerve 2003; 27: 265-284. .
39.
Karjalainen K, Malmivaara A, van Tulder M, et al. Multidisciplinary biopsychosocial rehabilitation for subacute low back pain in working-age adults: a systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine (Phila Pa 1976) 2001; 26: 262-269.
40.
Breivik H, Collett B, Ventafridda V, et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006; 10: 287-333.
41.
Nishida K, Kang JD, Gilbertson LG, et al. Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: an in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene. Spine (Phila Pa 1976) 1999; 24: 2419-2425.
42.
Cooper RG, Freemont AJ. TNF-αlpha blockade for herniated intervertebral disc-induced sciatica: a way forward at last? Rheumatology (Oxford) 2004; 43: 119-121.
43.
Karppinen J, Korhonen T, Malmivaara A, et al. Tumor necrosis factor-alpha monoclonal antibody, infliximab, used to manage severe sciatica. Spine (Phila Pa 1976) 2003; 28: 750-753.
44.
Negrini S, Fusci C, Atanasio S, et al. Low back pain: state of art. Eur J Pain 2008; Suppl 2: 52-56.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (
https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.